analytical services,
our world.

Your bridge between life changing therapies and patients.

PCI offers a global network of in-house analytical testing capabilities with laboratories located in North America, Europe, the UK and Asia Pacific, delivering analytical services from the earliest stages of pharmaceutical development through to commercialization, supporting manufacturing, packaging, release and distribution for global supply.

As an integrated, global CDMO, our in-house analytical testing capabilities provide a true end-to-end solution from development to commercialization.

Spanning the cycle.A truly global proposition.

Always growing, we are driving development and connecting commercialization, and with 4300 people in 30 global GMP facilities, we are local and global